rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-4-6
|
pubmed:abstractText |
Type 2 diabetes mellitus is characterized by insulin resistance and defects in insulin secretion from pancreatic beta-cells, which have been studied by using euglycemic/hyperinsulinemic clamps. However, it is difficult to study insulin resistance and beta-cell failure by these techniques in humans. Therefore, the aim of this study was to evaluate the effect of three different antidiabetic therapeutic regimens on insulin resistance and beta-cell activity by using a mathematical model, Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1075-2765
|
pubmed:author |
pubmed-author:Bermúdez-AriasFernandoF,
pubmed-author:Bermúdez-PirelaValmore JVJ,
pubmed-author:CanoClímacoC,
pubmed-author:CanoRaquelR,
pubmed-author:CiscekAnaA,
pubmed-author:ContrerasFreddyF,
pubmed-author:Hernández-HernándezRafaelR,
pubmed-author:IsrailiZafar HZH,
pubmed-author:LealElliuz MEM,
pubmed-author:LemusMiguel AMA,
pubmed-author:MedinaMayerlim TMT,
pubmed-author:SeyfiHamid AHA,
pubmed-author:SoukiAidaA,
pubmed-author:ValascoManuelM
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
194-202
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17414590-Blood Glucose,
pubmed-meshheading:17414590-Diabetes Mellitus, Type 2,
pubmed-meshheading:17414590-Diet,
pubmed-meshheading:17414590-Drug Therapy, Combination,
pubmed-meshheading:17414590-Female,
pubmed-meshheading:17414590-Hemoglobin A, Glycosylated,
pubmed-meshheading:17414590-Humans,
pubmed-meshheading:17414590-Hyperinsulinism,
pubmed-meshheading:17414590-Hypoglycemic Agents,
pubmed-meshheading:17414590-Insulin,
pubmed-meshheading:17414590-Insulin Resistance,
pubmed-meshheading:17414590-Insulin-Secreting Cells,
pubmed-meshheading:17414590-Male,
pubmed-meshheading:17414590-Metformin,
pubmed-meshheading:17414590-Middle Aged,
pubmed-meshheading:17414590-Models, Biological,
pubmed-meshheading:17414590-Motor Activity,
pubmed-meshheading:17414590-Sulfonylurea Compounds
|
pubmed:articleTitle |
Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
|
pubmed:affiliation |
Endocrine and Metabolic Diseases Research Center Dr. Félix Gómez, University of Zulia School of Medicine, Maracaibo, Venezuela. vbermudez@hotmail.com
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|